TFFP logo

TFF Pharmaceuticals (TFFP) Company Overview

Profile

Full Name:

TFF Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

October 25, 2019

Indexes:

Not included

Description:

TFF Pharmaceuticals focuses on developing innovative drug delivery systems using its patented Thin Film Freezing technology. This method enhances the solubility and bioavailability of medications, aiming to improve treatment options for patients with various conditions, particularly in the fields of respiratory and central nervous system disorders.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Feb 14, 2025

Recent annual earnings:

Feb 14, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Dec 19, 2023

Analyst ratings

Recent major analysts updates

Mar 28, 24 Roth MKM
Buy
May 25, 23 HC Wainwright & Co.
Buy
Mar 22, 23 JonesTrading
Buy
Mar 17, 23 HC Wainwright & Co.
Buy
Mar 29, 22 B. Riley Securities
Buy
Mar 5, 21 HC Wainwright & Co.
Buy
Feb 8, 21 HC Wainwright & Co.
Buy
Jul 8, 20 Maxim Group
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for TFF Pharmaceuticals?
  • Does TFF Pharmaceuticals pay dividends?
  • What sector is TFF Pharmaceuticals in?
  • What industry is TFF Pharmaceuticals in?
  • What country is TFF Pharmaceuticals based in?
  • When did TFF Pharmaceuticals go public?
  • Is TFF Pharmaceuticals in the S&P 500?
  • Is TFF Pharmaceuticals in the NASDAQ 100?
  • Is TFF Pharmaceuticals in the Dow Jones?
  • When was TFF Pharmaceuticals's last earnings report?
  • When does TFF Pharmaceuticals report earnings?
  • Should I buy TFF Pharmaceuticals stock now?

What is the ticker symbol for TFF Pharmaceuticals?

The ticker symbol for TFF Pharmaceuticals is NASDAQ:TFFP

Does TFF Pharmaceuticals pay dividends?

No, TFF Pharmaceuticals does not pay dividends

What sector is TFF Pharmaceuticals in?

TFF Pharmaceuticals is in the Healthcare sector

What industry is TFF Pharmaceuticals in?

TFF Pharmaceuticals is in the Biotechnology industry

What country is TFF Pharmaceuticals based in?

TFF Pharmaceuticals is headquartered in United States

When did TFF Pharmaceuticals go public?

TFF Pharmaceuticals's initial public offering (IPO) was on October 25, 2019

Is TFF Pharmaceuticals in the S&P 500?

No, TFF Pharmaceuticals is not included in the S&P 500 index

Is TFF Pharmaceuticals in the NASDAQ 100?

No, TFF Pharmaceuticals is not included in the NASDAQ 100 index

Is TFF Pharmaceuticals in the Dow Jones?

No, TFF Pharmaceuticals is not included in the Dow Jones index

When was TFF Pharmaceuticals's last earnings report?

TFF Pharmaceuticals's most recent earnings report was on Feb 14, 2025

When does TFF Pharmaceuticals report earnings?

The date for TFF Pharmaceuticals's next earnings report has not been announced yet

Should I buy TFF Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions